ARCHIVE

• Pfizer Health Research Forum
  November 21, 2005

• Dainippon Sumitomo Enjoying "Smooth Start": Mr Miyatake
  November 21, 2005

• R&D NEWS IN BRIEF
  November 21, 2005

• Costs of Domestic Clinical Trials Remain Excessive: Mr Nakajima of JPMA
  November 21, 2005

• FPMAJ, JPMA Petition on FY2006 Budget, Taxation System
  November 21, 2005

• Drug Benefits Discussed by EAD Director Futagawa
  November 21, 2005

• JMA Objects that GPs Income Is Not as High as Reported by Korosho
  November 21, 2005

• Medical Fees Must Be Reduced by at Least 3%: MOF Council
  November 21, 2005

• FPMAJ's Mr Mukaida Criticizes Korosho's Reform Proposals
  November 21, 2005

• MOF Proposes to Exclude "Non-prescription Drugs" from Insurance Coverage: Mr Mugitani
  November 21, 2005

• BUSINESS NEWS IN BRIEF
  November 21, 2005

• IMS Health Predicts 6-7% Growth in Global Drug Market in 2006
  November 21, 2005

• Worldwide Sales of Olmesartan to Top \100 Bil. in 2006: Daiichi Sankyo
  November 21, 2005

• Ono: Opalmon Tab, Long Allergy Season Boosts Sales 4.9%
  November 21, 2005

• AstraZeneca to Support Lung Cancer Awareness
  November 14, 2005

• Takeda: Ethical Drug Sales Up 8.8% at \500,900 Mil.
  November 14, 2005

• Eisai: Record Sales, Profits; Overseas Sales Break 50%
  November 14, 2005

• Santen: Ethical Drugs Drive Growth in Sales, Profits
  November 14, 2005

• Torii: Sales, Profits Hit by Slump in Major Products, TachoComb Transfer
  November 14, 2005

• Japan Tobacco: Pharma Division Sales Down 0.8%
  November 14, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 436
• 437
• 438
• 439
• 440
• 441
• 442
• 443
• 444
• …
• Next ›
• 最終 »